Skip to main content Back to Top


Doxycycline Hyclate Injection

Products Affected - Description

    • Doxycycline hyclate lyophilized powder for injection, Mylan Institutional, 100 mg, vial, 10 count, NDC 67457-0437-10

Reason for the Shortage

    • Mylan Institutional temporarily discontinued doxycycline 100 mg vials in March 2016.
    • Fresenius Kabi had doxycycline injection on shortage due to increased demand.

Available Products

    • Doxycycline hyclate lyophilized powder for injection, Fresenius Kabi, 100 mg, vial, 10 count, NDC 63323-0130-11

Estimated Resupply Dates

    • Fresenius Kabi has doxycycline 100 mg vials available.


Updated May 21, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 30, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins